F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Nihon Medi-Physics Co., Ltd. is a Japanese joint venture company located in Koto-ku focused on pharmaceutical preparations. The firm was founded in 1973. Nobuhiko Tamura is the current CEO of the company.\nThe company says this about itself: Nihon Medi-Physics is engaging in ensuring stable supply and research and development of the products as a leading manufacturer of radiopharmaceuticals in Japan. Based on the technological proficiency and trust built over the years, the company is also working on research and development of \"Theranostics (a combination of therapy and diagnosis),\" which is a novel medical technology to provide optimal medical service to each patient, as well as on the dissemination of nuclear medicine in Asian countries by licensing its products. The company will continue contributing to society by creating values as a life science company.

Fujian Zhongke Biological Co., Ltd., established on 2015-12-28, Business scope includes general items:Natural science research and experimental development;Technology promotion and application services;Agricultural Science Research and Experimental Development;vegetable planting;fruit planting;Chinese herbal medicine planting;spice crops;tea planting;Bio-organic fertilizer research and development;Non-Major Crop Seed Production;Agricultural machinery manufacturing;Agricultural Machinery Sales;Manufacturing of lighting fixtures;Lighting Sales;food business(Only sell prepackaged food);Food Internet Sales(Selling prepackaged food);Primary processing of edible agricultural products(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:pharmaceutical production;Health food production;fertilizer production;food production;Production of tea products(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Meiji Co., Ltd. produces and sells milk, dairy, confectioneries, and food. Its products include cheese, ice cream, chocolate, infant formula, whey protein, beauty supplements, and yogurt. The company was founded on December 21, 1917 and is headquartered in Tokyo, Japan.

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of small molecule drugs. Its products include original medicine such as Chidamide, Chiglitazar, Chiauranib. It also engages in technological licensing. The company was founded by Xian Ping Lu and Zhi Qiang Ning on March 21, 2001 and is headquartered in Shenzhen, China.

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Hinova Pharma is an innovative drug research and development manufacturer that provides users with compound HC-1119 androgen receptor (AR) antagonism by using drug discovery systems such as medicinal chemistry, biological screening, process research, quality research, clinical reporting, and clinical research. Drugs, HC-1102 androgen receptor inhibitors and other products, for the treatment of advanced prostate cancer and breast cancer.

Meiji Feed Co., Ltd., a subsidiary of Meiji Holdings Co., Ltd., is a Japanese company located in Tokyo that manufactures and wholesales dairy & cattle feeding products. The firm was founded in 1951.

NGK Insulators, Ltd. engages in the manufacture and sale of electric power-related equipment, industrial ceramics, and beryllium copper products. It operates through the following segments: Power, Ceramics, and Electronics. The Power segment manufactures and sells power insulators, devices, and sodium sulfur batteries. The Ceramics segment produces and sells automotive & industrial ceramics, industrial heating systems, and refractory materials. The Electronics segment manufactures and sells beryllium copper products, ceramics for industrial electronics & semiconductor manufacturing, electronic components, and molds. The company was founded on May 5, 1919 and is headquartered in Nagoya, Japan.

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Its clinical-stage drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator, CK-136, a novel cardiac troponin activator, reldesemtiv, a novel fast skeletal muscle troponin activator, aficamten, a novel cardiac myosin inhibitor, and CK-3772271, a novel cardiac myosin inhibitor. The company was founded by Ronald D. Vale, Lawrence S. B. Goldstein, James H. Sabry, and James A. Spudich in 1997 and is headquartered in South San Francisco, CA.

Takeda Pharmaceutical Company Ltd (武田薬品工業株式会社 Takeda Yakuhin Kōgyō Kabushiki-gaisha) is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 30,000 employees worldwide and achieved 16.2 billion USD in revenue during the 2012 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. In 2018, the company's largest selling product lines were Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.

Quest PharmaTech, Inc. is a biotechnology company, which develops and commercializes antibody based immunotherapeutic products for cancer. It focuses on developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications. The firm is developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target, truncated O-glycans on MUC16. The company was founded in 1996 and is headquartered in Edmonton, Canada.

Zhejiang Cancer Hospital is a Chinese private company located in Hangzhou. The firm operates as an cancer hospital.

Develops, manufactures and supplies cosmetic and therapeutic ingredients

CytoMed, Inc., a subsidiary of Takeda Pharmaceutical Co., Ltd., is an American company located in Cambridge, MA. The firm develops therapeutics for cancer treatment. On February 12, 1999 LeukoSite, Inc., now a subsidiary of Takeda Pharmaceutical Co., Ltd. acquired CytoMed, Inc. for $19.29 million.

BioInnovation LLC, based in Cambridge, Massachusetts, is an early stage life sciences investment and consulting firm. We make seed investments, act as institutional co-founders, and provide strategic and operational services. As investors and entrepreneurs ourselves, we understand the needs of early-stage companies, and the end-to-end requirements needed to start, grow and build successful ventures.

MetaTech (AP) Inc. engages in the distribution of semiconductor components, modules, and electronic materials. It has two business segments Electronics and Biomedicine. The company's business activities include the retail and wholesale of electronic materials; and provision of information technology software and data processing services. Its products used in DC converters, battery management, high current drivers, LDO, PWM, GPS chipsets, high quality PC board level interconnecting devices, comprehensive flash products, standard flash, combo memory, compact flash, disk on chip, modem, WAN, LAN, smart card reader, audio/video, meters, electronic connectors and medical care products. MetaTech was founded on September 17, 1998 and is headquartered in New Taipei, Taiwan.